Facilitation of central imidazoline I1‐site/extracellular signal‐regulated kinase/p38 mitogen‐activated protein kinase signalling mediates the hypotensive effect of ethanol in rats with acute renal failure
Open Access
- 28 October 2009
- journal article
- research article
- Published by Wiley in British Journal of Pharmacology
- Vol. 158 (6) , 1629-1640
Abstract
Background and purpose: This study investigated the role of central sympathetic activity and related mitogen‐activated protein kinase (MAPK) signalling in the cardiovascular effects of ethanol in a model of acute renal failure (ARF).Experimental approach: The effects of pharmacological interventions that inhibit peripheral or central sympathetic activity or MAPK on the cardiovascular actions of ethanol in rats with ARF induced by glycerol were evaluated.Key results: Glycerol (50%, 10 mL·kg−1, i.m.) caused progressive increases and decreases in blood pressure (BP) and heart rate (HR) respectively. Subsequent i.v. ethanol (0.25 or 1 g·kg−1) elicited dose‐related changes in BP (decreases) and HR (increases). These effects were replicated after intracisternal (i.c.) administration of ethanol. Blockade of nicotinic cholinoceptors (nAChR, hexamethonium, 20 mg·kg−1) or α1‐adrenoceptors (prazosin, 1 mg·kg−1) attenuated cardiovascular effects of ethanol. Ethanol hypotension was also attenuated after the centrally acting sympatholytic drug moxonidine (selective I1‐site agonist, 100 µg·kg−1i.v.), but not guanabenz (selective α2‐receptor agonist, 30 µg·kg−1, i.v.), suggesting involvement of central circuits of I1sites in ethanol‐evoked hypotension. Selective blockade I1sites (efaroxan) but not α2(yohimbine) adrenoceptors abolished the hypotensive response to ethanol. Intracisternal administration of PD98059 or SB203580, inhibitors of extracellular signal‐regulated kinase (ERK 1/2) and p38 MAPK, respectively, reduced the hypotensive action of moxonidine or ethanol. When used simultaneously, the two MAPK inhibitors produced additive attenuation of ethanol hypotension.Conclusions and implications: Sympathoinhibitory pathways of central I1‐sites and downstream ERK/p38 MAPK signalling were involved in the hypotensive action of ethanol in ARF.Keywords
This publication has 50 references indexed in Scilit:
- Guide to Receptors and Channels (GRAC), 3rd editionBritish Journal of Pharmacology, 2008
- Amelioration of myoglobinuric renal damage in rats by chronic exposure to flavonol-rich red wineNephrology Dialysis Transplantation, 2004
- Central blockade of nitric oxide synthesis reduces moxonidine‐induced hypotensionBritish Journal of Pharmacology, 2004
- Cardiovascular Risk in Patients with Early Renal InsufficiencyAmerican Journal of Cardiovascular Drugs, 2002
- High prevalence of alcoholism in dialysis patientsAmerican Journal of Kidney Diseases, 2000
- Estrogen‐Dependent Hypotensive Effects of Ethanol in Conscious Female RatsAlcohol, Clinical and Experimental Research, 1999
- Renal adenosine A1 receptor binding characteristics and mRNA levels during the development of acute renal failure in the ratBritish Journal of Pharmacology, 1997
- Acute depressor effect of alcohol in patients with essential hypertension.Hypertension, 1992
- Evidence for a direct effect of alcohol consumption on blood pressure in normotensive men. A randomized controlled trial.Hypertension, 1985
- Alcohol Consumption and Blood PressureNew England Journal of Medicine, 1977